NCT01890967
A Study of LY3015014 in Participants With High Cholesterol
See it on ClinicalTrials.gov ↗519 people
46.4%
53.6%
241 womenmiddle line = equal numbers278 men
- Phase
- PHASE2
- Paid for by
- Eli Lilly and Company
- Finished
- 2014-06
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 58.4 Years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 68.6% · Asian 26.4% · Black / African American 4.4% · More than one race 0.6% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Women who cannot become pregnant, or women who are not pregnant or breast feeding and agree to use a reliable method of birth control to prevent pregnancies”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Women who cannot become pregnant, or women who are not pregnant or breast feeding and agree to use a reliable method of birth control to prevent pregnancies”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Have had recent heart attack, stroke, blood clot or heart surgery, have planned heart or blood vessel surgery, or has a heart that does not pump sufficiently well”
- No diabetes
Women with diabetes were turned away.
“Have diabetes that requires an injectable medication (including insulin), or have diabetes that is poorly controlled”
- No cancer
Women with current or past cancer were turned away.
“Have or suspected to have any cancer or malignant tumor”
Study titles and rules are shown in their original English.